$VSEE News: VSee New AI Doctor Notes Reduces Documentation

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams Lee Adams #21238
204
$VSEE News: VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911

SAN JOSE, Calif.--(BUSINESS WIRE)-- Fourth paragraph, first sentence of release dated July 14, 2025 should read: Dr. Ramon Lizardo MD, CEO of Tele911 (instead of Dr. Ramone Lizardo, MD, CEO of Tele911).

The updated release reads:

VSEE NEW AI DOCTOR NOTES REDUCES DOCUMENTATION TIME 93% – TRANSFORMING VIRTUAL EMERGENCY CARE FOR TELE911

VSee Health, Inc. (Nasdaq: VSEE) a leading provider of secure digital health solutions, today announced the launch of its new AI doctor notes, one of the solutions in its AI solutions suite.

VSee has partnered with Tele911, the largest national telemedicine emergency room diversion service, to integrate VSee’s AI Doctor Notes into its virtual emergency care workflow. Emergency medicine demands rapid decision-making and high patient throughput. The integration has drastically reduced Tele911 physician’s charting time by 93% from 15 minutes per visit to under 1 minute, potentially increasing physician visit capacity.

This new VSee AI solution automatically transcribes visits and generates structured SOAP notes with ICD codes in two clicks, allowing Tele911 physicians to reclaim valuable time. Now, instead of manual documentation, clinicians can focus on patient care.

Dr. Ramon Lizardo, MD, CEO of Tele911 states "VSee’s AI Doctor Notes integration has been a game-changer for our physicians. As the nation’s leading virtual ER from 911 calls, demand is high and efficiency is critical. With two clicks it allows our physicians to eliminate documentation busywork, so they can devote their full attention to patients and to improving care delivery at scale."

Dr. Milton Chen, PhD, CEO of VSee adds: "Our AI SOAP notes isn’t just about speed—it’s about restoring the human connection in medicine. Tele911’s adoption proves its transformative potential in high-acuity telemedicine."

VSee’s AI-powered documentation solution is available both as an integrated feature in the VSee digital health platform or as a stand alone solution that can be used side-by-side with any EHR. It presents a compelling opportunity for hospitals, clinics, and investors looking to enhance clinical efficiency and scalability.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects, “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC’s website at www.sec.gov . The Company does not assume any obligation to update or revise any such forward- looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to rely on forward-looking statements.

About VSee Health

VSee Health (Nasdaq: VSEE) is a rapidly growing leader in AI-powered telehealth, redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by 1,000+ clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the entire nation of Qatar, VSee Health provides foundational infrastructure for digital healthcare and delivers turnkey solutions to optimize healthcare operations while increasing billable patient visits and provider efficiency. Visit vseehealth.com.

About Tele911

Tele911 Inc. is a healthcare technology company delivering telemedicine and patient navigation solutions tailored to the emergency medical services sector. The company was founded by leaders in emergency medicine and EMS, whose mission is to improve patients’ lives and expand access to care, while reducing unnecessary healthcare costs and strain on providers. Tele911’s telehealth platform provides integrated, intuitive, user-friendly clinical workflows. This enables more effective, efficient patient triage, care delivery, reporting and follow up to meet the needs of fire departments, EMS agencies, health systems, and local and national payer and risk-bearing organizations. For more information, visit tele911.com.

https://cts.businesswire.com/ct/CT?id=bwnews&...mp;lang=en

View source version on businesswire.com: https://www.businesswire.com/news/home/20250714034916/en/

VSee Health
Anne Chang
media@vsee.com

Tele911
Josue Perez-Davalos
Chief of Staff
josue@tele911.com
831-566-7996

VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

Source: VSee Health, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 8

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 44

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 46

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 4

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 8

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 4

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 2

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 2

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 5

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 2

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading

Top 5 Most Recently Viewed Articles

Akeso Reports Progress with Ivonescimab in Cancer Treatment

Updated Category News Views 232

Akeso Moves Forward with Promising Cancer Therapy Trials Akeso Biopharma is excited to share fantastic news regarding its latest clinical endeavors in the realm of cancer treatment. The company has successfully enrolled the first patient in the AK112-309 trial, a pivotal Phase III study designed to evaluate the efficacy of ivonescimab in combination with another regimen...

Continue Reading
Quanex Building Products Raises Dividend for Shareholders

Updated Category News Views 168

Quanex Building Products Announces Quarterly Dividend HOUSTON — Quanex Building Products Corporation (NX) is pleased to announce that its Board of Directors declared a quarterly cash dividend of $0.08 per share on its common stock. This dividend is scheduled to be paid to shareholders of record on a specified date, indicating the company's commitment to rewarding its...

Continue Reading
Trump Calls for Transparency from COVID Drug Manufacturers

Updated Category News Views 204

Trump Demands Drug Firms Reveal COVID Vaccine Data Former President Donald Trump has issued a call to pharmaceutical companies to provide concrete evidence regarding the effectiveness of their COVID-19 drugs, particularly emphasizing the need for transparency surrounding their vaccine data. Transparency in Pharmaceuticals On his social media platform, Trump urged these...

Continue Reading
AECOM Technology Sees Stock Surge to Record $108.26 High

Updated Category News Views 106

AECOM Technology Stock Peaks at $108.26 AECOM Technology Corporation has recently achieved a major milestone in the stock market, reaching an impressive high of $108.26. This achievement not only reflects the robust growth of the infrastructure consulting firm but also represents a 43.14% increase in its stock value over the past year. Investors have been showing strong...

Continue Reading
China's Return to US Soybean Purchases Sparks Market Optimism

Updated Category News Views 678

China Resumes U.S. Soybean Purchases Amid Market Changes Recent reports indicate that China has made its initial purchase of U.S. soybeans from the current year’s harvest, marking the end of a prolonged boycott. This significant development comes just ahead of a highly anticipated summit between U.S. President Donald Trump and Chinese President Xi Jinping. Market...

Continue Reading